Covid-19 roundup: WHO is­sues 'strong' rec­om­men­da­tion for Pfiz­er's Paxlovid but wants more price trans­paren­cy

4 years ago
Pharma
Coronavirus

Bio­gen pulls the plug on its Eu­ro­pean ap­pli­ca­tion for con­tro­ver­sial Alzheimer's drug

4 years ago
Pharma

Scynex­is builds out case for its an­ti­fun­gal in the hos­pi­tal­ized set­ting, but in­vestors don't seem hap­py

4 years ago
R&D
Pharma

Astel­las writes off $560M loss, drop­ping gene ther­a­py pro­grams, on­col­o­gy an­ti­body

4 years ago
R&D

Mi­cro­cap biotech seeks a merg­er or new in­vest­ment af­ter PhI­II flop — shares soar

4 years ago
Financing
R&D

Serum In­sti­tute CEO, head of world's biggest vac­cine mak­er, says Covid shot pro­duc­tion was halt­ed in De­cem­ber

4 years ago
Pharma
Coronavirus

San­drock’s first month at Voy­ager sours as shares crum­ble on Levin, Paul’s move to step off the board

4 years ago
People
Startups

Will a biotech ri­val fi­nal­ly shake up Ab­b­Vie's $2B Botox cos­met­ic fran­chise? Re­vance will find out soon

4 years ago
FDA+

Bay­er plucks an­oth­er on­col­o­gy ex­ec away from Glax­o­SmithK­line as it con­tin­ues prostate can­cer push

4 years ago
People
R&D

Mov­ing on from Us­ama Ma­lik's in­sid­er trad­ing im­broglio, Fore re­sets at the top; Take­da spin­out turns to Neu­rana CEO ...

4 years ago
Peer Review

FDA's ODAC votes unan­i­mous­ly that fu­ture PI3K in­hibitors should in­clude ran­dom­ized da­ta for blood can­cers

4 years ago
Pharma
FDA+

Louisiana AG sues Unit­ed­Health Group sub­sidiaries over fraud al­le­ga­tions in drug pric­ing case

4 years ago
Pharma
Law

Crowd­ed rheuma­toid arthri­tis cat­e­go­ry gets JAK re­al­i­ty check, while TNF stal­warts con­tin­ue to dom­i­nate: study

4 years ago
Pharma
Marketing

Eli Lil­ly and Boehringer In­gel­heim urge women to be­come their own heart health ad­vo­cates in new cam­paign

4 years ago
Pharma
Marketing

Biotech, aca­d­e­m­ic lead­ers en­cour­age FDA to con­sid­er T-cell as­sess­ment in Covid-19 vac­cine tri­als

4 years ago
FDA+
Coronavirus

Har­vard re­searchers call on Con­gress to clean up phar­ma com­pa­nies' mess of re­stric­tions on con­tract phar­ma­cies un­der ...

4 years ago
Pharma

An­oth­er new man­u­fac­tur­ing site for NC; Bio­Cen­triq ac­quired by South Ko­re­an com­pa­ny

4 years ago
Manufacturing

How No­var­tis as­sess­es a drug's prob­a­bil­i­ty of suc­cess pri­or to the piv­otal tri­al

4 years ago
R&D

Seagen to build man­u­fac­tur­ing site from ground up near Wash­ing­ton home

4 years ago
Manufacturing

Catal­ent drops $350M to ex­pand In­di­ana site that in­cludes Mod­er­na-ded­i­cat­ed line

4 years ago
Manufacturing

Fol­low­ing BeiGene, Zai Lab changes au­di­tors amidst SEC threat of delist­ing

4 years ago
Financing
China

Sanofi of­floads two late-stage drugs to vir­tu­al­ly un­known neu­ro and psy­che­del­ic biotech

4 years ago
Deals
R&D

FDA signs off on Gilead­'s mas­sive new CAR-T man­u­fac­tur­ing site in Mary­land

4 years ago
Cell/Gene Tx
Manufacturing

Ora­sis will ship its Vuity eye drop com­peti­tor to the FDA lat­er this year with two PhI­II wins

4 years ago
R&D
First page Previous page 535536537538539540541 Next page Last page
A service from the Financial Times